Aurora Cannabis Inc
TSX:ACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aurora Cannabis Inc
Total Liabilities & Equity
Aurora Cannabis Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aurora Cannabis Inc
TSX:ACB
|
Total Liabilities & Equity
CA$775.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
47%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Total Liabilities & Equity
$26.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Liabilities & Equity
CA$1.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
22%
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Liabilities & Equity
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
60%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Total Liabilities & Equity
$236.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
58%
|
CAGR 10-Years
95%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Total Liabilities & Equity
CA$1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
Aurora Cannabis Inc
Glance View
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.
See Also
What is Aurora Cannabis Inc's Total Liabilities & Equity?
Total Liabilities & Equity
775.3m
CAD
Based on the financial report for Dec 31, 2025, Aurora Cannabis Inc's Total Liabilities & Equity amounts to 775.3m CAD.
What is Aurora Cannabis Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
47%
Over the last year, the Total Liabilities & Equity growth was -11%. The average annual Total Liabilities & Equity growth rates for Aurora Cannabis Inc have been -9% over the past three years , -23% over the past five years , and 47% over the past ten years .
